Healthcare provider profile · identity verified

Patricia Oconnor, M.D.

Family Practice · PINOLE, CA · NPI 1720006380

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	122
Amlodipine Besylate	Amlodipine Besylate	376	109
Losartan Potassium	Losartan Potassium	303	85
Levothyroxine Sodium	Levothyroxine Sodium	227	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	226	37
Metformin Hcl	Metformin Hcl	223	65
Hydrochlorothiazide	Hydrochlorothiazide	217	63
Lisinopril	Lisinopril	201	59
Metoprolol Succinate	Metoprolol Succinate	144	37
Simvastatin	Simvastatin	143	39
Allopurinol	Allopurinol	115	33
Atenolol	Atenolol	113	32
Gabapentin	Gabapentin	108	31
Glipizide	Glipizide	100	28
Lorazepam	Lorazepam	97	24
Albuterol Sulfate Hfa	Albuterol Sulfate	93	34
Alendronate Sodium	Alendronate Sodium	89	28
Jardiance	Empagliflozin	85	25
Pantoprazole Sodium	Pantoprazole Sodium	84	27
Metoprolol Tartrate	Metoprolol Tartrate	75	22
Furosemide	Furosemide	73	17
Omeprazole	Omeprazole	70	25
Tramadol Hcl	Tramadol Hcl	69	18
Rosuvastatin Calcium	Rosuvastatin Calcium	67	24
Fluoxetine Hcl	Fluoxetine Hcl	62	13
Ezetimibe	Ezetimibe	58	20
Lovastatin	Lovastatin	57	17
Trazodone Hcl	Trazodone Hcl	57	17
Zolpidem Tartrate	Zolpidem Tartrate	53	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	52	17
Pravastatin Sodium	Pravastatin Sodium	51	14
Potassium Chloride	Potassium Chloride	50	15
Carvedilol	Carvedilol	49	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	17
Quetiapine Fumarate	Quetiapine Fumarate	48	11
Carisoprodol	Carisoprodol	45	suppressed
Celecoxib	Celecoxib	45	15
Clonidine Hcl	Clonidine Hcl	43	12
Eliquis	Apixaban	43	13
Montelukast Sodium	Montelukast Sodium	43	14
Mirtazapine	Mirtazapine	41	suppressed
Alprazolam	Alprazolam	40	suppressed
Ozempic	Semaglutide	40	suppressed
Famotidine	Famotidine	39	14
Pioglitazone Hcl	Pioglitazone Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Ibuprofen	Ibuprofen	36	16
Sertraline Hcl	Sertraline Hcl	36	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	35	suppressed
Meloxicam	Meloxicam	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	19
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Naproxen	Naproxen	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	18
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Diazepam	Diazepam	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Nystatin	Nystatin	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Estradiol	Estradiol	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Colchicine	Colchicine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Azithromycin	Azithromycin	12	11
Benazepril Hcl	Benazepril Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Finasteride	Finasteride	11	suppressed
Methimazole	Methimazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error